Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT) 2023-12-29 07:30
Meihua International Medical Technologies Co., Ltd. Announces Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering 2023-12-28 22:00
HANSIZHUANG Sets Sail in Indonesia Market 2023-12-28 21:51
Heranova Lifesciences Debuts with $13.5 Million Seed and Seed+ Round Funding to Offer Integrated Clinical Solutions to Women's Health 2023-12-28 21:00
RemeGen's Pioneering RC88 Receives IND Approval from US FDA for Platinum-Resistant Recurrent Ovarian Cancer Treatment 2023-12-28 15:45
Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China 2023-12-28 08:00
Visionary Excellence Recognized: VISTA Eye Specialist Clinches Top Honor at Health and Wellness Brand Awards 2023-12-28 08:00
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA 2023-12-27 20:50
Seegene obtains ISO45001 certification 2023-12-27 20:00
AIA Hong Kong "Health & Wellness Survey" Defies Stereotypes: Family Overtakes Money as Key to Happiness, Redefines Health and Happiness 2023-12-27 16:03
Rx-360® Announces 2024 Board of Directors 2023-12-27 13:00
Caliway to Present CBL-514 Phase 2 Study Results for Subcutaneous Fat Reduction at IMCAS 2024 2023-12-27 11:49
PharmaBlock Opens HPAPI GMP Facility at Zhejiang Manufacturing Site 2023-12-27 11:37
Innovent and SanegeneBio Enter Strategic Collaboration to Develop siRNA Drug for the Treatment of Hypertension 2023-12-27 08:00
Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs 2023-12-26 17:26
PharmaBlock Obtained ISO 50001 Certification, Advancing Sustainable Development 2023-12-26 11:00
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy 2023-12-25 10:15
APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia 2023-12-24 17:53
GenSci Launches Global Innovation Hub in Shanghai 2023-12-23 15:41
Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered Drug Development in China 2023-12-22 13:26
1 109 110 111 112 113 963